Dr Lynn Walton Whelchel Jr, MD | |
273 Smith Hill Rd, Colebrook, CT 06021-7093 | |
(860) 379-7120 | |
Not Available |
Full Name | Dr Lynn Walton Whelchel Jr |
---|---|
Gender | Male |
Speciality | Thoracic Surgery (cardiothoracic Vascular Surgery) |
Location | 273 Smith Hill Rd, Colebrook, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124396767 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 016089 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Lynn Walton Whelchel Jr, MD 273 Smith Hill Rd, Colebrook, CT 06021-7093 Ph: (860) 379-7120 | Dr Lynn Walton Whelchel Jr, MD 273 Smith Hill Rd, Colebrook, CT 06021-7093 Ph: (860) 379-7120 |
News Archive
After working to ensure the U.S. had access to enough H1N1 (swine flu) vaccine, health officials may now face a new dilemma - a vaccine surplus, the Associated Press reports.
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the launch of a novel solution for detecting genetic copy number variations (CNVs) associated with disease susceptibility, drug response and cancer progression.
More than ninety percent of men who receive appropriate radiation dose levels with permanent radiation seed implants to treat their prostate cancer are cured of their cancer eight years after diagnosis, according to a study released in the February 1 issue of the International Journal for Radiation Oncology - Biology - Physics, the official journal of ASTRO.
UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Keppra (levetiracetam) tablets and oral solution as adjunctive therapy in the treatment of partial onset seizures in adults and children one month of age and older with epilepsy.
Kathleen Sakamoto, MD, PhD, and Irving Weissman, MD, of the Stanford University School of Medicine and Lucile Packard Children's Hospital, have received a $1.37 million grant from CureSearch for Children's Cancer to research the effects of an antibody that has been shown to be effective against human cancers in animal models.
› Verified 9 days ago